# CorneaGen - Boston – FDA Inspection, Mar 28, 2013

Source: https://www.keypedia.com/records/fda_inspections/corneagen-boston/25aa4223-7973-4e2e-b56f-2b10ebc7d2d0
Source feed: FDA_Inspections

> FDA inspection 824487 of CorneaGen - Boston, March 28, 2013. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 1271. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 824487
- Company Name: CorneaGen - Boston
- Inspection Date: 2013-03-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1257221 - 2024-12-20](https://www.keypedia.com/records/fda_inspections/corneagen-boston/43ca6f6d-9fc0-4574-8a2c-ae5be00b98c8)
- [FDA Inspection 1207719 - 2023-06-09](https://www.keypedia.com/records/fda_inspections/corneagen-boston/1eb901f6-19b0-405f-8bab-144f6e931eea)
- FDA Inspection 1121216 - 2020-03-05
- FDA Inspection 1068364 - 2018-09-12
- FDA Inspection 941531 - 2015-08-20

Company: https://www.keypedia.com/companies/corneagen-boston/78964c02-d403-4377-8609-2434e1adaef8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
